Literature DB >> 12807743

Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.

Nghia T V Le1, Des R Richardson.   

Abstract

Iron (Fe) chelators are potential antitumor agents. Cellular Fe depletion results in a G1/S arrest but the precise molecular mechanisms involved remain unclear. Recent studies have shown that this process is complex with multiple cell cycle molecules being involved. We previously showed that Fe chelators such as 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311) were far more potent antitumor agents than the clinically used ligand, desferrioxamine (DFO). To further characterize the effects of chelators on cell cycle arrest, we compared their activity with the DNA-damaging agents actinomycin D (Act D) and cisplatin (CP). These latter two compounds increase the expression of p53 and its target genes such as the universal cyclin-dependent kinase inhibitor, p21(CIP1/WAF1). Incubation of normal and neoplastic cells with all agents resulted in increased nuclear p53, the effect being pronounced for Act D and CP. As expected, both Act D and CP also markedly increased nuclear p21(CIP1/WAF1) protein levels, while DFO and 311 caused a significant (P<0.0004) decrease. This latter effect was surprising, as these chelators markedly increased mRNA levels of this molecule. Immunofluorescence studies showed that Act D and CP caused nuclear localization of p21(CIP1/WAF1). In contrast, the chelators prevented translation of p21(CIP1/WAF1). This did not appear to be due to a general effect of the chelators on preventing translation, as transferrin receptor 1 was markedly up-regulated 15- to 21-fold by DFO and 311. Combination of 311 with Act D or CP prevented translation of p21(CIP1/WAF1) and its nuclear localization observed with these DNA-damaging agents. Significantly, the effect of chelation on reducing nuclear p21(CIP1/WAF1) was reversed by the Fe donor ferric ammonium citrate, indicating that p21(CIP1/WAF1) translation was dependent on intracellular Fe levels. This study demonstrates that while Fe chelators markedly up-regulate the mRNA levels of p21(CIP1/WAF1) they paradoxically inhibit translation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807743     DOI: 10.1093/carcin/bgg042

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription.

Authors:  Namita Kumari; Sergey Iordanskiy; Dmytro Kovalskyy; Denitra Breuer; Xiaomei Niu; Xionghao Lin; Min Xu; Konstantin Gavrilenko; Fatah Kashanchi; Subhash Dhawan; Sergei Nekhai
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.

Authors:  Y Yu; Y Suryo Rahmanto; D R Richardson
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

3.  Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content.

Authors:  Suneet Kaur; Gautam Srivastava; Amar Nath Sharma; Ravinder S Jolly
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

4.  Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways.

Authors:  Shiro Mizuno; Herman J Bogaard; Norbert F Voelkel; Yukihiro Umeda; Maiko Kadowaki; Shingo Ameshima; Isamu Miyamori; Takeshi Ishizaki
Journal:  Respir Res       Date:  2009-03-06

5.  Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2.

Authors:  Shai J White; Laura M Kasman; Margaret M Kelly; Ping Lu; Laura Spruill; Paul J McDermott; Christina Voelkel-Johnson
Journal:  Free Radic Biol Med       Date:  2007-07-03       Impact factor: 7.376

6.  Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.

Authors:  Andrea Orue; Valery Chavez; Mary Strasberg-Rieber; Manuel Rieber
Journal:  BMC Cancer       Date:  2016-11-18       Impact factor: 4.430

7.  Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators.

Authors:  Gang Cheng; Jacek Zielonka; Micael Hardy; Olivier Ouari; Christopher R Chitambar; Michael B Dwinell; Balaraman Kalyanaraman
Journal:  Oncotarget       Date:  2019-05-28

8.  Effects of damage-regulated autophagy regulator gene on the SGC7901 human gastric cancer cell line.

Authors:  Bao-Song Zhu; Kui Zhao; Xin Jia; Yong-You Wu; Chun-Gen Xing
Journal:  Oncol Lett       Date:  2014-06-04       Impact factor: 2.967

9.  Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation.

Authors:  Zhen-Hua Shi; Fang-Fang Shi; Yue-Qi Wang; Alex D Sheftel; Guangjun Nie; Ya-Shuo Zhao; Lin-Hao You; Yu-Jing Gou; Xiang-Lin Duan; Bao-Lu Zhao; Hong-Meng Xu; Chun-Yan Li; Yan-Zhong Chang
Journal:  Cell Mol Life Sci       Date:  2014-09-12       Impact factor: 9.261

10.  Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.

Authors:  Rayan S Moussa; Zaklina Kovacevic; Des R Richardson
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.